Checkpoint Therapeutics Inc

+0.03 (+0.54%)
7:42:34 PM EDT: $5.63 -0.01 (-0.18%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)52.75M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.04 Million
Adjusted EPS-$1.33
See more estimates
10-Day MA$5.42
50-Day MA$5.31
200-Day MA$9.88
See more pivots

Checkpoint Therapeutics Inc Stock, NASDAQ:CKPT

95 Sawyer Road, Suite 110, Waltham, Massachusetts 02453
United States of America
Phone: +1.781.652.4500
Number of Employees: 14


Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX. The company was founded on November 10, 2014 and is headquartered in Waltham, MA.